Nearly 30 Early-Stage Medical Technology Companies Confirmed to Date to Present at Medtech Insight and Windhover Information's 'In3 Medical Device Summit' Conference, June 21-23, 2006, in San Francisco.

NEWPORT BEACH, Calif. -- Program to Feature Partnering Software and 3 Tracks of Presentations by 60+ Emerging Medical Technology Companies Seeking Funding and/or Strategic Partnership

Medtech Insight has announced that nearly 30 emerging medical technology companies seeking investment and/or funding opportunities are confirmed to date to present at its largest medical technology strategic investment and partnering event for medical technology executives, the "Investment In Innovation (In3) Medical Device Summit." The In3 Medical Device Summit (www.meddevicesummit.com), being held June 21-23, 2006, at The Palace Hotel in San Francisco, is the most important venue of its kind for previewing cutting-edge emerging medical technology companies and engaging with the biggest dealmakers in the industry, including hundreds of senior executives from the device industry and healthcare investment community.

The In3 Medical Device Summit program will be unlike any other past Medtech Insight In3 event: it will feature a 50% larger speaker faculty, including 60+ early-stage medical technology industry presenters focused into 3 Tracks, with more VC and large company presentations. Attendees will also benefit from unique partnering software that allows attendees before and during the conference to access a wealth of searchable information on other attending companies, including detailed technical, non-confidential company and delegate profile information, a database of licensing opportunities provided by the attendees themselves, and the ability to communicate with and directly schedule meetings with prospective partners.

The conference will include presentations by more than 60 emerging medical technology companies in all, focused into 3 Tracks, each followed by break-out sessions in private conference rooms (the majority presenting for the first time at an In3 event). Track 1 will include Cardiovascular and Peripheral Vascular Diagnostics and Therapeutics companies; Track 2 is comprised of Orthopedics and Spine companies; and Track 3 includes Other High-Growth Technologies such as Drug Delivery, Gastrointestinal, General Surgery, Imaging, Metabolic Disorders, Neurology, Oncology, Ophthalmology, Tissue Engineering, and Uro/Gynecology, among others. Track 1 presenters confirmed to date include Alchimer, Cardium Therapeutics, Design Medical, Edrich Health Technologies, FlowMedic, Meridian Medical, Myotech, Percardia, Vascular Reconditioning, and VasoGenix Pharmaceuticals. Confirmed Track 2 presenters to date include Acologix, BioniCare Medical Technologies, ISTO Technologies, SpineVision, SpinX Technologies, Tibion, and VitalWear, and Track 3 presenters to date include AION Diagnostics, BioImagene, Biosan Medical, CleveX, CVAC Systems, EMcision, GlucoLight, LiverCyte, Nanolution, and StemCapture. Visit the In3 Summit Web site at www.meddevicesummit.com for full event details.

Other highlights of the event include partnering opportunities, lessons learned and practical advice from the venture capital community; keynote presentations by prominent device industry executives; case studies and lessons learned from senior level, mid-size, large company and VC roundtable and feature presentations; and a variety of focused start-up company educational workshops.

Participating speakers at the In3 Medical Device Summit to date include Tom Fogarty, Founder, Fogarty Engineering; Hanson S. Gifford III, President and CEO, The Foundry; Trevor Moody, Partner, Frazier Healthcare Ventures; Rich Ferrari, Managing Director, De Novo Ventures; Leslie Bottorff, General Partner, Medical Technology Onset Ventures; Sami Hamade, Vice President, Compass Group, Guidant Corp.; and David L. Douglass, General Partner, Delphi Ventures; Brent Ahrens, General Partner, Canaan Partners, and Bryant Zanko, Vice President, Business Development at Stryker Corp. In addition, David Cassak, Managing Partner at Windhover Information will give the State of the Start-up Industry Address titled "A Market Analysis of Where Medical Technology Companies are Going."

Co-sponsors for the In3 Summit include AdvaMed, Battelle, Business Wire, Finnegan Henderson Farabow Garrett & Dunner LLP, Medical Capital Advisors, Medmarc and The Hartford, The Harvard Clinical Research Institute (HCRI), Reimbursement Principles, Ronald Trahan Associates, Teledyne Medical Microsystems, The MedTech Group, and Underwriters Laboratories.

To register to attend or if your early-stage company is interested in presenting, call Kristy Grimes of Medtech Insight at 480-985-9512, 888-202-5939 toll-free in the U.S., e-mail [e-mail], or register on the In3 Medical Device Summit Web site at www.meddevicesummit.com. Through March 31, 2006, attendees registering for the conference can save $300 off the $1,495 registration fee.

Medtech Insight's medical technology investment and partnering conferences have drawn over 5,850 attendees and more than 650 innovative early-stage presenting companies since their inception, making them the premier investment, partnering and networking event in the medical technology industry.

About Medtech Insight

Medtech Insight, a division of Windhover Information Inc., is the leading provider of business information and market intelligence for the medical technology marketplace. For more on the company's products and services, please see www.medtechinsight.com.